Aoxing Pharmaceutical (AXN) Reports Q2 EPS of $0.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailAoxing Pharmaceutical (NYSE: AXN) reported Q2 EPS of $0.03, versus $0.01 reported last year. Revenue for the quarter came in at $8.2 million, versus $6.4 million reported last year.
For earnings history and earnings-related data on Aoxing Pharmaceutical (AXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Oaktree unit launches secondary offering of 6.3M TORM shares
- RBC Capital maintains Outperform rating on Insmed amid CFO change
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
